Keiichi Kobayashi

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas

Hideyuki Arita, Kai Yamasaki, Yuko Matsushita et al. · Acta Neuropathologica Communications · 2016 · 265 citations · Full text

Medicine, Oncology, Radiation Oncology +17

What limits the encoding effect of note-taking? A meta-analytic examination

Keiichi Kobayashi · Contemporary Educational Psychology · 2005 · 230 citations

Social Sciences, Educational Psychology, Psychology +11

Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors

Kohei Fukuoka, Yonehiro Kanemura, Tomoko Shofuda et al. · Acta Neuropathologica Communications · 2018 · 148 citations · Full text

Medicine, Oncology, Pathology +17

ENHANCED TUMOR GROWTH ELICITED BY L-TYPE AMINO ACID TRANSPORTER 1 IN HUMAN MALIGNANT GLIOMA CELLS

Keiichi Kobayashi, Akiko Ohnishi, Promsuk Jutabha et al. · Neurosurgery · 2008 · 137 citations

Life Sciences, Biochemistry, Oncology +13

TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma

Kenji Fujimoto, Hideyuki Arita, Kaishi Satomi et al. · Acta Neuropathologica · 2021 · 107 citations

Medicine, Molecular Genetics, Oncology +15